Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 2308

1.

External Validation of the Simple NULL-PLEASE Clinical Score in Predicting Outcome of Out-of-Hospital Cardiac Arrest.

Potpara TS, Mihajlovic M, Stankovic S, Jozic T, Jozic I, Asanin MR, Ahmad R, Lip GYH.

Am J Med. 2017 Jun 21. pii: S0002-9343(17)30618-6. doi: 10.1016/j.amjmed.2017.05.035. [Epub ahead of print]

PMID:
28647407
2.

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

Kuo L, Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Lip GYH, Chen SA.

J Am Heart Assoc. 2017 Jun 23;6(6). pii: e005307. doi: 10.1161/JAHA.116.005307.

3.

Brugada syndrome: A general cardiologist's perspective.

Polovina MM, Vukicevic M, Banko B, Lip GYH, Potpara TS.

Eur J Intern Med. 2017 Jun 20. pii: S0953-6205(17)30263-7. doi: 10.1016/j.ejim.2017.06.019. [Epub ahead of print] Review.

PMID:
28645806
4.

Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry.

Shantsila A, Shantsila E, Beevers DG, Lip GYH.

J Hypertens. 2017 Jun 14. doi: 10.1097/HJH.0000000000001446. [Epub ahead of print]

PMID:
28622157
5.

Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.

Lip GYH, Skjøth F, Nielsen PB, Kjældgaard JN, Larsen TB.

JAMA Cardiol. 2017 Jun 14. doi: 10.1001/jamacardio.2017.1883. [Epub ahead of print]

PMID:
28614582
6.

Renin-angiotensin blockade in atrial fibrillation: where are we now?

Shahid F, Lip GYH, Shantsila E.

J Hum Hypertens. 2017 Jul;31(7):425-426. doi: 10.1038/jhh.2017.6. No abstract available.

PMID:
28588316
7.

Clinical Stroke prevention in atrial fibrillation.

Voukalis C, Shantsila E, Lip GY.

J R Coll Physicians Edinb. 2017 Mar;47(1):13-23. doi: 10.4997/JRCPE.2017.105.

PMID:
28569277
8.

Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Deng H, Bai Y, Shantsila A, Fauchier L, Potpara TS, Lip GYH.

Clin Res Cardiol. 2017 May 30. doi: 10.1007/s00392-017-1123-0. [Epub ahead of print]

PMID:
28560516
9.

Stroke Prevention in Atrial Fibrillation: Focus on Latin America.

Massaro AR, Lip GYH.

Arq Bras Cardiol. 2016 Dec;107(6):576-589. doi: 10.5935/abc.20160116. Epub 2016 Aug 11. Portuguese, English.

10.

Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).

Lip GYH, Coca A, Kahan T, Boriani G, Manolis AS, Olsen MH, Oto A, Potpara TS, Steffel J, Marín F, de Oliveira Figueiredo MJ, de Simone G, Tzou WS, En Chiang C, Williams B.

Eur Heart J Cardiovasc Pharmacother. 2017 Jun 20. doi: 10.1093/ehjcvp/pvx019. [Epub ahead of print]

PMID:
28541499
11.

Sex-Related Differences in the Clinical Events of Patients With Atrial Fibrillation - The Fushimi AF Registry.

Ogawa H, Hamatani Y, Doi K, Tezuka Y, An Y, Ishii M, Iguchi M, Masunaga N, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GY, Akao M; Fushimi AF Registry Investigators.

Circ J. 2017 May 25. doi: 10.1253/circj.CJ-17-0071. [Epub ahead of print]

12.

Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.

Verdecchia P, Reboldi G, Angeli F, Mazzotta G, Lip GYH, Brueckmann M, Kleine E, Wallentin L, Ezekowitz MD, Yusuf S, Connolly SJ, Di Pasquale G.

Europace. 2017 May 17. doi: 10.1093/europace/eux022. [Epub ahead of print]

PMID:
28520924
13.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Freedman B, Camm J, Calkins H, Healey JS, Rosenqvist M, Wang J, Albert CM, Anderson CS, Antoniou S, Benjamin EJ, Boriani G, Brachmann J, Brandes A, Chao TF, Conen D, Engdahl J, Fauchier L, Fitzmaurice DA, Friberg L, Gersh BJ, Gladstone DJ, Glotzer TV, Gwynne K, Hankey GJ, Harbison J, Hillis GS, Hills MT, Kamel H, Kirchhof P, Kowey PR, Krieger D, Lee VWY, Levin LÅ, Lip GYH, Lobban T, Lowres N, Mairesse GH, Martinez C, Neubeck L, Orchard J, Piccini JP, Poppe K, Potpara TS, Puererfellner H, Rienstra M, Sandhu RK, Schnabel RB, Siu CW, Steinhubl S, Svendsen JH, Svennberg E, Themistoclakis S, Tieleman RG, Turakhia MP, Tveit A, Uittenbogaart SB, Van Gelder IC, Verma A, Wachter R, Yan BP; AF-Screen Collaborators.

Circulation. 2017 May 9;135(19):1851-1867. doi: 10.1161/CIRCULATIONAHA.116.026693. Review.

PMID:
28483832
14.

Atrial Fibrillation and End Stage Renal Failure in Patients Receiving Dialysis: Balancing the Risks and Benefits of Stroke Prevention.

Voukalis C, Lip GYH.

Can J Cardiol. 2017 Jun;33(6):705-707. doi: 10.1016/j.cjca.2017.02.010. Epub 2017 Feb 28. No abstract available.

PMID:
28457737
15.

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care.

Lane DA, Skjøth F, Lip GYH, Larsen TB, Kotecha D.

J Am Heart Assoc. 2017 Apr 28;6(5). pii: e005155. doi: 10.1161/JAHA.116.005155.

17.

Response by Bai et al to Letter Regarding Article, "Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis".

Bai Y, Shantsila A, Lip GYH.

Stroke. 2017 Jun;48(6):e149. doi: 10.1161/STROKEAHA.117.017460. Epub 2017 Apr 28. No abstract available.

PMID:
28455316
18.

Retinal vessel diameters and reactivity in diabetes mellitus and/or cardiovascular disease.

Heitmar R, Lip GYH, Ryder RE, Blann AD.

Cardiovasc Diabetol. 2017 Apr 26;16(1):56. doi: 10.1186/s12933-017-0534-6.

19.

Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.

Proietti M, Boriani G, Laroche C, Diemberger I, Popescu MI, Rasmussen LH, Sinagra G, Dan GA, Maggioni AP, Tavazzi L, Lane DA, Lip GYH; EORP-AF General Pilot Registry Investigators.

Europace. 2017 Apr 1;19(4):535-543. doi: 10.1093/europace/euw150.

PMID:
28431068
20.

The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia.

Bai Y, Wang YL, Shantsila A, Lip GYH.

Chest. 2017 Apr 17. pii: S0012-3692(17)30721-3. doi: 10.1016/j.chest.2017.03.048. [Epub ahead of print]

PMID:
28427968

Supplemental Content

Loading ...
Support Center